Acquiring Company
Avista Capital Partners
Acquired Company
Terrats Medical
New York
BarcelonaHealth CareVenture CapitalManufacturingBiotechnologyHealth CareMedical DeviceDescription
Avista Capital Partners has announced its acquisition of Terrats Medical from Miura Partners, with support from Terrats' founders who have reinvested in the company and will continue to lead the business. The acquisition aims to support Terrats' international expansion and other growth initiatives, building upon the company's strong position in the dental prosthetics market and reinforcing its global presence.
Quick answer
Avista Capital Partners is acquiring Terrats Medical, announced February 16, 2024. Avista Capital Partners is based in New York, New York, United States.
- How much did Avista Capital Partners pay for Terrats Medical?
- The deal value was not disclosed.
- What does Avista Capital Partners do?
- Founded in 2005, Avista Capital is a leading New York-based private equity firm with over $8 billion invested in more than 40 growth-oriented healthcare businesses globally.
- Where are Avista Capital Partners and Terrats Medical based?
- Avista Capital Partners is based in New York, New York, United States. Terrats Medical is based in Barcelona, Catalonia, Spain.
Source: Fundz verified event record.
Other recent acquisitions in Venture Capital and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Novo Holdings to Acquire Catalent (February 5, 2024)
- Haemonetics Corporation completes acquisition of Attune Medical to expand its medical technology solutions (April 1, 2024)
- Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction (March 25, 2024)
- Abbvie To Acquire Landos Biopharma, Further Strengthening Its Portfolio In Inflammatory And Autoimmune Diseases (March 25, 2024)
- Bristol Myers Squibb completes acquisition of Karuna Therapeutics, Inc. to strengthen its neuroscience portfolio (March 18, 2024)
- Medline Industries, LP completes acquisition of AG Cuffill® from Hospitech Respiration Ltd. (March 7, 2024)
Who to call at Avista Capital Partners, and when
When Avista Capital Partners changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Avista Capital Partners raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Avista Capital Partners, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Avista Capital Partners. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Avista Capital Partners makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Terrats Medical?
Terrats Medical was acquired by Avista Capital Partners, based in New York. The deal was reported on February 16, 2024. Founded in 2005, Avista Capital is a leading New York-based private equity firm with over $8 billion invested in more than 40 growth-oriented healthcare businesses globally. Avista Capital Partners is privately held and operates in Health Care.
When did Avista Capital Partners acquire Terrats Medical?
Avista Capital Partners's acquisition of Terrats Medical was reported on February 16, 2024. Avista Capital Partners has announced its acquisition of Terrats Medical from Miura Partners, with support from Terrats' founders who have reinvested in the company and will continue to lead the business. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Terrats Medical do?
Terrats Medical is a leading global provider of dental prosthetics, including abutments and implants. It is privately held, operating in Manufacturing, and is based in Barcelona.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.